Evidence map›Paper›PMID 26195823›Full record

ArticleThe Biochemical journal2015

The mucolipidosis IV Ca2+ channel TRPML1 (MCOLN1) is regulated by the TOR kinase.

Rob U Onyenwoke, Jonathan Z Sexton, Feng Yan, María Cristina Huertas Díaz, Lawrence J Forsberg, Michael B Major, Jay E Brenman

Abstract read
In one paragraph

Article in The Biochemical journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The protein interaction networks of mucolipins and two-pore channels.Biochimica et biophysica acta. Molecular cell research · 2019
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. TRPML3/BK complex promotes autophagy and bacterial clearance by providing a positive feedback regulation of mTOR via PI3P.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Vascular mechanotransduction.Physiological reviews · 2023
    Review
  11. New Insights into the Regulation of mTOR Signaling via CaInternational journal of molecular sciences · 2023
    Review
  12. Article
  13. TRPML1 and TFEB, an Intimate Affair.Handbook of experimental pharmacology · 2023
    Article
  14. Article
  15. Review
  16. TheFrontiers in cell and developmental biology · 2022
    Article
  17. Cells · 2021
    Article
  18. Review
  19. Exploiting the Potential ofBiomedicines · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rob U OnyenwokeBiomanufacturing Research Institute and Technology Enterprise (BRITE), North Carolina Central University, Durham, NC 27707, U.S.A. ronyenwo@nccu.edu).
Jonathan Z SextonBiomanufacturing Research Institute and Technology Enterprise (BRITE), North Carolina Central University, Durham, NC 27707, U.S.A.
Feng YanDepartment of Cell Biology and Physiology, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, U.S.A.
María Cristina Huertas DíazNeuroscience Center, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, U.S.A.
Lawrence J ForsbergNeuroscience Center, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, U.S.A.
Michael B MajorDepartment of Cell Biology and Physiology, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, U.S.A.
Jay E BrenmanDepartment of Cell Biology and Physiology, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, U.S.A. Neuroscience Center, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, U.S.A.

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
Integrated Training in Cancer Model SystemsT32CA009156 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J. · 1985 to 2020
$19.7M
Exploitation of Near-Haploid Human Cells for Functional Gene DiscoveryDP2OD007149 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAJOR, MICHAEL BENJAMIN · 2010 to 2010
$2.2M
Genetic Elucidation of AMP-Activated Protein Kinase Signaling MechanismsR01NS080108 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BRENMAN, JAY · 2012 to 2016
$1.6M
High-Content Screening for Peroxisome Biogenesis for Type-II Diabetes.R01DK088248 · NIDDK · NORTH CAROLINA CENTRAL UNIVERSITY · PI BRENMAN, JAY, SEXTON, JONATHAN ZACHARY · 2011 to 2013
$980k
NCI NIH HHS T32 CA009156NIDDK NIH HHS R01 DK088248NIH HHS 1-DP2-OD007149-01NINDS NIH HHS NS080108NINDS NIH HHS R01 NS080108
6 · The paper itself

Abstract

Autophagy is a complex pathway regulated by numerous signalling events that recycles macromolecules and may be perturbed in lysosomal storage disorders (LSDs). During autophagy, aberrant regulation of the lysosomal Ca(2+) efflux channel TRPML1 [transient receptor potential mucolipin 1 (MCOLN1)], also known as MCOLN1, is solely responsible for the human LSD mucolipidosis type IV (MLIV); however, the exact mechanisms involved in the development of the pathology of this LSD are unknown. In the present study, we provide evidence that the target of rapamycin (TOR), a nutrient-sensitive protein kinase that negatively regulates autophagy, directly targets and inactivates the TRPML1 channel and thereby functional autophagy, through phosphorylation. Further, mutating these phosphorylation sites to unphosphorylatable residues proved to block TOR regulation of the TRPML1 channel. These findings suggest a mechanism for how TOR activity may regulate the TRPML1 channel.

Indexed as

Amino Acid SequenceAMP-Activated Protein KinasesAnimalsAnimals, Genetically ModifiedAutophagyBinding SitesCalcium SignalingDrosophila melanogasterDrosophila ProteinsFemaleGene Knockdown TechniquesGenes, InsectHEK293 CellsHumansMaleModels, BiologicalAMP-Activated Protein KinasesAMPKalpha protein, DrosophilaDrosophila ProteinsMCOLN1 protein, humanMTOR protein, humanRecombinant Fusion ProteinsTOR Serine-Threonine KinasesTransient Receptor Potential Channelsadenosine 5′-phosphate (AMP)-activated protein kinaseautophagylysosomal storage diseasemammalian target of rapamycinmucolipidosis type IVtransient receptor potential channels

Identifiers

PMID26195823
PMCPMC4613499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.